Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-06-07

Clinical Trial Update: Efficacy and Safety of Cyclosporine Microemulsion in Diabetic Adult Stable Liver Transplant Recipients [Phase 4]

View source ↗

Summary

Phase 4 trial update on the efficacy and safety of cyclosporine microemulsion in diabetic adult stable liver transplant recipients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • cyclosporine microemulsion (cyclosporine)

Snippet

Sponsor: Novartis | Conditions: Liver Transplant | Phase 4 | Status: COMPLETED